FIELD: medicine.
SUBSTANCE: group of inventions relates to medicine, pharmaceutical chemistry, pharmacology and pharmaceutics. Use of 6-(3,3-dimethyl-3,4-dihydroisoquinolin-1-yl) aminohexane acid of the formula I as a compound, providing analgesic effect and helps to relieve the mechanical somatic pain during diseases, accompanied by frank pain syndrome, and pharmaceutical composition based on it. 1.
EFFECT: technical result of the invention is to implement a stated purpose with efficiency comparable to ketorolac with low toxicity; pharmaceutical composition provides a prolonged analgesic effect 8 hours after oral intake to rats.
2 cl, 14 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF PRODUCING N-(3,3-DIMETHYL-3,4-DIHYDROISOQUINOLYL-1)-6-AMINOCAPROIC ACID | 2014 |
|
RU2563244C1 |
4-(3,4-DIBROMOTHIOPHENE CARBONYL)-10-(2-ETHOXYACETYL)-2,6,8,12-TETRAACETYL-2,4,6,8,10,12-HEXAAZATETRACYCLO[5,5,0,0,0]DODECANE AS AN ANALGESIC AGENT AND METHOD FOR PRODUCTION THEREOF | 2021 |
|
RU2786231C1 |
ANALGETIC AGENT | 2001 |
|
RU2223763C2 |
4-(2-ETOXYACETYL)-2,6,8,10,12-PENTAACETYL-2,4,6,8,10,12-HEXAAZATETRACYCLO [5,5,0,0,0] DODECANE AS ANALGETIC AND METHOD OF ITS OBTAINING | 2023 |
|
RU2808905C1 |
4-(3,4-DIBROMOTHYOPHENE CARBONYL)-2,6,8,10,12-PENTAACETYL-2,4,6,8,10,12 HEXAAZAISOWURTZITANE AS AN ANALGESIC AGENT AND METHOD FOR ITS PREPARATION | 2021 |
|
RU2769523C1 |
SYNTHETIC ANALGESIC AGENT AND METHOD FOR TREATMENT BASED ON THIS AGENT | 2006 |
|
RU2322977C1 |
NEPHOPAM SUPPOSITORIES FOR THE TREATMENT OF ACUTE AND CHRONIC PAIN SYNDROME ON A LIPOPHILIC BASIS AND THE METHOD FOR THEIR PREPARATION | 2017 |
|
RU2661618C1 |
ANALGESIC AGENT OF PEPTIDE STRUCTURE BASED ON TRIDECAPEPTIDE CONTAINING D-OCTAARGININE VECTOR | 2013 |
|
RU2538727C1 |
PHARMACEUTICAL COMPOSITIONS OF THIOCHROMENOL BASED ON A HEXAHYDRO-HETEROCYCLIC COMPOUND WITH ANALGESIC EFFECT, AND METHODS FOR THEIR USE IN DOMESTIC AND FARM ANIMALS | 2022 |
|
RU2812294C2 |
ANALGESIC SUBSTANCE OF ENDOGENOUS NATURE, PHARMACEUTICAL COMPOSITION BASED THEREON AND METHODS OF USE THEREOF | 2023 |
|
RU2823100C2 |
Authors
Dates
2018-03-26—Published
2016-11-03—Filed